크리스퍼 테라퓨틱스 (CRSP)

04:44 AM

CRISPR Therapeutics And Intellia Therapeutics: Balancing Market Uncertainty Against Pipeline Catalysts - Seeking Alpha

04:44 AM

02:04 AM

Genome Engineering Market Generated Opportunities, Future - openPR.com

02:04 AM

May 04, 2025

Susquehanna Fundamental Investments LLC Makes New Investment in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

May 04, 2025

May 04, 2025

CRISPR Therapeutics AG (NASDAQ:CRSP) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat

May 04, 2025

May 03, 2025

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know - MSN

May 03, 2025

May 03, 2025

Barclays PLC Sells 27,790 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

May 03, 2025

May 02, 2025

Raymond James Financial Inc. Acquires New Stake in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

May 02, 2025

May 02, 2025

CRISPR Therapeutics AG (CRSP) Advances But Underperforms Market: Key Facts - MSN

May 02, 2025

Apr 30, 2025

2 Beaten-Down Stocks With Incredible Upside Potential - Yahoo Finance

Apr 30, 2025

Apr 30, 2025

T. Rowe Price Investment Management Inc. Raises Stake in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Apr 30, 2025

Apr 29, 2025

XTX Topco Ltd Has $351,000 Stock Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Apr 29, 2025

Apr 28, 2025

Legal & General Group Plc Decreases Stock Position in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Apr 28, 2025

Apr 26, 2025

CRISPR Therapeutics to Report Q1 Earnings: What's in the Cards? - MSN

Apr 26, 2025

Apr 25, 2025

CRISPR Therapeutics AG (CRSP) Stock Falls Amid Market Uptick: What Investors Need to Know - MSN

Apr 25, 2025

Apr 24, 2025

Crispr Therapeutics Benefits From Diverse Gene Editing Portfolio; Positive Long-Term Outlook - Morningstar

Apr 24, 2025

Apr 24, 2025

Prediction: 1 Biotech Stock That Could Surpass Pfizer by 2030 - 24/7 Wall St.

Apr 24, 2025

Apr 24, 2025

Capital International Sarl Has $7.36 Million Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Apr 24, 2025

Apr 23, 2025

Wells Fargo & Company MN Has $8.66 Million Stock Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Apr 23, 2025

Apr 23, 2025

Leerink Partnrs Issues Negative Estimate for CRSP Earnings - MarketBeat

Apr 23, 2025

Apr 23, 2025

‘Incoming Regulatory Tailwinds’ to Spur 90% Upside for CRISPR Therapeutics Stock, Says BMO Capital - Yahoo Finance

Apr 23, 2025

Apr 22, 2025

Jump Financial LLC Increases Stock Position in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Apr 22, 2025

Apr 22, 2025

Advisory Services Network LLC Reduces Position in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Apr 22, 2025

Apr 22, 2025

Crispr Therapeutics AG: Promising Growth with Casgevy Launch and Innovative Pipeline - TipRanks

Apr 22, 2025

Apr 21, 2025

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It - MSN

Apr 21, 2025

Apr 21, 2025

Geode Capital Management LLC Has $39.41 Million Stock Position in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Apr 21, 2025

Apr 21, 2025

Capital International Investors Grows Position in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Apr 21, 2025

Apr 20, 2025

5 Monster Stocks -- Such as Coupang -- to Hold for the Next 10 Years - The Motley Fool

Apr 20, 2025

Apr 19, 2025

CRISPR Therapeutics (NASDAQ:CRSP) Shares Down 4%Should You Sell? - MarketBeat

Apr 19, 2025

Apr 18, 2025

CRISPR Therapeutics AG (NASDAQ:CRSP) Shares Sold by Reynders McVeigh Capital Management LLC - MarketBeat

Apr 18, 2025

Apr 18, 2025

CRISPR Therapeutics stock pops following disclosure of RFK Jr. investment - MSN

Apr 18, 2025

Apr 17, 2025

CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade - MSN

Apr 17, 2025

Apr 17, 2025

BofA Adjusts Price Target on CRISPR Therapeutics to $80 From $86, Keeps Buy Rating - marketscreener.com

Apr 17, 2025